Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paired-like homeobox protein 2B (PHOX2B) is a transcription factor exclusively expressed in the nervous system, critical for the differentiation and survival of sympathetic neurons and chromaffin cells. It determines the neurotransmitter phenotype of noradrenergic neurons, such as those in the locus coeruleus, by acting as a DNA-binding regulator for various gene promoters and response elements. Mutations—especially polyalanine tract expansions—cause congenital central hypoventilation syndrome, and other pathogenic variants predispose to Hirschsprung's disease, neuroblastoma, and ROHHAD. PHOX2B is a highly sensitive and specific marker for detecting neuroblastoma via immunohistochemistry, particularly useful in challenging diagnostic scenarios. Although not a direct drug target, it is essential in disease mechanisms and considered a therapeutic target in gene-based approaches and in the context of cancer predisposition.
Not directly targeted by drugs; its dysfunction due to mutations affects other downstream targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paired-like homeobox protein 2B (PHOX2B).